Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Feb;31(2):570-578.
doi: 10.1111/jce.14333. Epub 2020 Jan 15.

Clinical and genetic evaluation after sudden cardiac arrest

Affiliations
Review

Clinical and genetic evaluation after sudden cardiac arrest

Stephanie L Harris et al. J Cardiovasc Electrophysiol. 2020 Feb.

Abstract

Sudden cardiac arrest (SCA) and sudden cardiac death (SCD) can be attributed to cardiac, respiratory, metabolic, and toxicologic etiologies. Most cases of SCD are caused by coronary artery disease and approximately 40% of cardiac arrests are unexplained. Inherited arrythmias and cardiomyopathies are important contributors to SCA and SCD. Identifying an inherited condition after such an event not only has important ramifications for the individual, but also for relatives who may be at risk for the familial condition. This review will provide an overview of inherited cardiovascular disorders than can predispose to SCA/SCD, review the diagnostic evaluation for an individual and/or family after an SCA/SCD, and discuss the role of genetic testing.

Keywords: arrhythmia; cardiomyopathy; gene; genetic testing; mutation; sudden cardiac arrest; sudden cardiac death.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
A) Pedigree illustrating the affected proband (III-2) and her first-degree at-risk relatives (II-2, II-3, III-1, III-3, IV-2). B) Pedigree illustrating autosomal dominant inheritance with reduced penetrance (III-3), age-dependent penetrance (IV-2), and the role of cascade genetic testing. Legend: squares indicate males, circles indicate females; shaded indicates affected; positive sign indicates presence of genetic variant, negative sign indicates absence of genetic variant; star indicates first-degree relative of proband
Figure 2.
Figure 2.
Suggested algorithm for evaluation of SCA survivors and families after a SCD. Specific testing considerations are discussed in the manuscript text.

Similar articles

Cited by

References

    1. Bagnall RD, Weintraub RG, Ingles J, et al. A prospective study of sudden cardiac death among children and young adults. N Engl J Med. 2016;374(25):2441–2452. doi:10.1056/NEJMoa1510687 - DOI - PubMed
    1. Ackerman MJ, Priori SG, Willems S, et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies. Europace. 2011;13(8):1077–1109. doi:10.1093/europace/eur245 - DOI - PubMed
    1. Hosseini SM, Kim R, Udupa S, et al. Reappraisal of reported genes for sudden arrhythmic death: Evidence-based evaluation of gene validity for brugada syndrome. Circulation. 2018;138(12):1195–1205. doi:10.1161/CIRCULATIONAHA.118.035070 - DOI - PMC - PubMed
    1. Towbin JA, McKenna WJ, Abrams DJ, et al. 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy. Hear Rhythm. 2019. doi:10.1016/j.hrthm.2019.05.007 - DOI - PubMed
    1. Hershberger RE, Givertz MM, Ho CY, et al. Genetic Evaluation of Cardiomyopathy—A Heart Failure Society of America Practice Guideline. J Card Fail. 2018;24(5):281–302. doi:10.1016/j.cardfail.2018.03.004 - DOI - PMC - PubMed

Publication types

MeSH terms